10:08 AM
Feb 14, 2017
 |  BC Extra  |  Financial News

Barer among investors acquiring NexImmune

An investor group including former CEOs of Celgene Corp. (NASDAQ:CELG) and Medtronic plc (NYSE:MDT) has acquired immuno-oncology company NexImmune Inc. (Gaithersburg, Md.) for an undisclosed amount.

The group includes Sol Barer, the former Celgene chairman and CEO who is now chairman of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA); his son Joshua Barer, a managing director...

Read the full 280 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >